Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
Titel:
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
Auteur:
Loibl, Sibylle O'Shaughnessy, Joyce Untch, Michael Sikov, William M Rugo, Hope S McKee, Mark D Huober, Jens Golshan, Mehra von Minckwitz, Gunter Maag, David Sullivan, Danielle Wolmark, Norman McIntyre, Kristi Ponce Lorenzo, Jose J Metzger Filho, Otto Rastogi, Priya Symmans, W Fraser Liu, Xuan Geyer Jr, Charles E